Online Consultation with Oncologist Doctors Abroad — Page 4

Dr. Ali Ihsan Anadolulu leads internal medicine at Central Hospital. He provides online consultations for patients seeking expert guidance on complex digestive and oncologic issues.

• Trained at Istanbul University Cerrahpaşa – one of Turkey's most prestigious medical schools
• Specializes in gastroenterology and internal medicine to address systemic health concerns
• Performs advanced endoscopic procedures for precise diagnostic evaluations
• Authored numerous scientific publications and textbooks to educate other physicians
• Focuses on pediatric gastrointestinal surgery and minimally invasive techniques

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Dr. Mariam Abu Zeid is a clinical oncologist at Shefaa Al Orman International Oncology Hospitals. She is certified by the European Society for Medical Oncology. Dr. Abu Zeid treats solid tumors and hematologic cancers. She holds a Ph.D. in Clinical Oncology and Nuclear Medicine from Ain Shams University.

• Administers chemotherapy, immunotherapy, and targeted treatments for various cancer types.
• Oversees oncology clinical trials and manages treatment-related toxicities.
• Coordinates patient care within multidisciplinary teams for complex staging and diagnosis.
• Practices at an ESMO-accredited center that treats approximately 6,000 patients annually.

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Prof. Enriqueta Felip is the President of the Oncology Commission at Vall d’Hebron University Hospital. She provides online consultations for patients with lung cancer and thoracic malignancies.

• Received the first ESMO Women for Oncology Award for her professional leadership
• Professor of Medicine at the Universitat de Vic training future oncologists
• Leads clinical trials investigating new therapies and pharmacogenomic methods for personalized care
• Board member of the International Association for the Study of Lung Cancer (IASLC)
• Vice-President of the Spanish Society of Medical Oncology (SEOM) until recently

Dr. Auala Hubert heads the Gastrointestinal Cancer Center at Hadassah Medical Center. He provides online consultation with oncologist services for digestive system tumors.

• Dual-qualified as a medical oncologist and a radiotherapist
• Specializes in esophagus, stomach, pancreas, and colon cancers
• Expert in HIPEC – delivering heated chemotherapy directly into the abdomen
• Certified by the American USMLE for high medical standards
• Member of the Israel Society of Clinical Oncology

Dr. Ana Oaknin is the Co-Chair of the GEICO Group. She leads Spanish ovarian cancer research and coordinates national research teams.

• Heads the Gynecological Tumor Unit at Vall d Hebron University Hospital
• Authored 100 scientific publications on gynecological cancer and immunology
• Expert in DNA repair mechanisms during online consultation with oncologist
• Faculty member at the European Society of Medical Oncology (ESMO)
• Leads international clinical trials for novel gynecological tumor treatments

Dr. Nir Kleinmann directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is a pioneer in kidney-sparing laser surgery for complex tumors. Forbes and ResultMed named him among Israel’s Best Doctors for 2025 and 2026. Dr. Kleinmann uses a unique dual-laser system to preserve organ function during cancer treatment.

• Completed urological fellowships at Thomas Jefferson University and McMaster University.
• Expert in minimally invasive treatments for UTUC, kidney stones, and prostate cancer.
• Served as a researcher in the OLYMPUS trial for non-surgical chemoablation.
• Fellow of the American Endourology Society with over 60 scientific publications.

Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.

• Heads the clinical research unit focusing on molecular oncology.
• Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
• Member of the American Society of Clinical Oncology (ASCO).
• Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.

Dr. Francesc Bosch leads the experimental hematology laboratory at Vall d’Hebron Hospital. He offers online consultation with oncologist for chronic lymphocytic leukemia and lymphomas.

• Directs over 80 clinical trials testing new blood cancer drugs
• President of the Spanish Group for Chronic Lymphocytic Leukemia study
• Published over 100 articles in journals like Nature Medicine
• Specializes in molecular technologies to analyze hematological diseases
• Completed a post-doctoral fellowship at Columbia University in New York

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Prof. Beni Boursi is a leading specialist at Sheba Medical Center. He provides expert second opinions during an online consultation with an oncologist.

• Trained in gastrointestinal oncology at the University of Pennsylvania
• Completed elective medical oncology training at MD Anderson Cancer Center
• Founded the ECOG-ACRIN Microbiome Working Group to study cancer treatment response
• Developed predictive models for early diagnosis of colorectal and pancreatic cancers
• Published research in top-tier scientific journals including Science

Dr. Abraham Avigdor is the Director of the Institute of Hematology at Sheba Medical Center. He is a global authority on lymphoma, CAR-T therapy, and complex blood cancers. Dr. Avigdor founded the Israeli Lymphoma Working Group. He helps lead a clinic ranked 7th worldwide by Newsweek in 2026.

• Authored over 130 scientific publications on hemato-oncology and cellular therapy.
• Pioneered the integration of CAR-T cell therapy for lymphoma and myeloma.
• Leads allogeneic and autologous bone marrow transplantation programs.
• Served as the Chairman of the Israeli Lymphoma Study Group.

Dr. Jesus Soberino is a lead clinical oncologist at Hospital Quiron Barcelona. He specializes in breast cancer and melanoma during online consultations with oncologists.

• Researcher at the Vall d’Hebron Institute of Oncology (VHIO) in Spain
• Participated in clinical trials for immunotherapy and targeted hormone treatments
• Helped gain approval for CDK4/6 inhibitors palbociclib and ribociclib
• Collaborates with international groups to develop new cancer drugs
• Expert in overcoming hormone therapy resistance in metastatic breast cancer

Dr. Avichai Shimoni is the Director of Bone Marrow Transplantation at Sheba Medical Center. He treats complex blood cancers. He completed a specialized fellowship at the MD Anderson Cancer Center. Dr. Shimoni uses allogeneic and autologous transplants for high-risk patients. He is a professor and Chairman of Hematology at Tel Aviv University.

• Named among Israel’s Best Doctors by Forbes for 2025 and 2026.
• Authored over 250 scientific papers on cellular therapies and transplantation.
• Provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Hila Magen is a leading Israeli hemato-oncologist at Sheba Medical Center. She heads the Multiple Myeloma and Amyloidosis Unit. Dr. Magen specializes in treating complex plasma cell disorders and high-risk myeloma. She is a principal investigator for innovative point-of-care CAR-T therapy programs. Her work brings advanced immunotherapies into routine clinical care.

• Authored over 100 scientific publications and landmark myeloma studies.
• Completed fellowships at MD Anderson and University of Arkansas for Medical Sciences.
• Performs CAR-T cell therapy and bone marrow transplantations.
• Works at Sheba Medical Center, ranked 7th worldwide in 2026 by Newsweek.

Dr. Aleix Prat holds three patents in genomic medicine. He leads breast cancer programs at Hospital Clinic of Barcelona and IOB–Quiron Salud for online oncology consultations.

• President of the Board of SOLTI – a major Spanish breast cancer research group
• Expert in molecular subtypes – uses genetic markers to improve diagnostic accuracy for patients
• Author of over 160 publications including research on novel drug clinical trials
• Professor at the University of Barcelona directing the Breast Pathology Master's program
• Executive Committee member of the Breast International Group (BIG)

Professor Francesc Graus is a pioneer who established the global criteria for diagnosing paraneoplastic neurological syndromes. He leads neuro-oncology at Hospital Quiron Barcelona.

• Completed a neuro-oncology fellowship at Memorial Sloan-Kettering Cancer Center in New York
• Founding President of the European Association of Neuro-Oncology (EANO)
• Specializes in treating brain tumors including gliomas, lymphomas, and glioblastomas
• Expert in neurotoxicities – nerve damage caused by immune checkpoint inhibitors or transplants
• Former Chief of Neurology at Hospital Clinic Barcelona – a top university hospital